293 related articles for article (PubMed ID: 19095140)
1. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Stein EA
J Am Coll Cardiol; 2008 Dec; 52(25):2206-9. PubMed ID: 19095140
[No Abstract] [Full Text] [Related]
2. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
Smith D
Mt Sinai J Med; 2008; 75(2):143-7. PubMed ID: 18500716
[No Abstract] [Full Text] [Related]
3. Is carotid intima-media thickness a reliable clinical predictor?
Spence JD
Mayo Clin Proc; 2008 Nov; 83(11):1299-300; author reply 1300-1. PubMed ID: 18990332
[No Abstract] [Full Text] [Related]
4. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
[TBL] [Abstract][Full Text] [Related]
5. Niacin compared with ezetimibe.
Duivenvoorden R; Vergeer M; Kastelein JJ
N Engl J Med; 2010 Mar; 362(11):1046-7; author reply 1048. PubMed ID: 20301795
[No Abstract] [Full Text] [Related]
6. The HALTS trial--halting atherosclerosis or halted too early?
Blumenthal RS; Michos ED
N Engl J Med; 2009 Nov; 361(22):2178-80. PubMed ID: 19915216
[No Abstract] [Full Text] [Related]
7. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
Fleg JL; Mete M; Howard BV; Umans JG; Roman MJ; Ratner RE; Silverman A; Galloway JM; Henderson JA; Weir MR; Wilson C; Stylianou M; Howard WJ
J Am Coll Cardiol; 2008 Dec; 52(25):2198-205. PubMed ID: 19095139
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy with ezetimibe or niacin in high-risk patients.
Kastelein JJ; Bots ML
N Engl J Med; 2009 Nov; 361(22):2180-3. PubMed ID: 19915218
[No Abstract] [Full Text] [Related]
9. Niacin compared with ezetimibe.
Roman MJ
N Engl J Med; 2010 Mar; 362(11):1047-8; author reply 1048. PubMed ID: 20301796
[No Abstract] [Full Text] [Related]
10. The role of lipid-lowering treatment in carotid intima-media thickness.
Kotsis V
Am J Hypertens; 2006 Jun; 19(6):654-5. PubMed ID: 16733241
[No Abstract] [Full Text] [Related]
11. Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
Colatsky TJ
Curr Opin Investig Drugs; 2009 Mar; 10(3):239-44. PubMed ID: 19333881
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
Mookadam F; Moustafa SE; Lester SJ; Warsame T
Prev Cardiol; 2010; 13(4):186-97. PubMed ID: 20860643
[TBL] [Abstract][Full Text] [Related]
13. Extended-release niacin or ezetimibe and carotid intima-media thickness.
Taylor AJ; Villines TC; Stanek EJ; Devine PJ; Griffen L; Miller M; Weissman NJ; Turco M
N Engl J Med; 2009 Nov; 361(22):2113-22. PubMed ID: 19915217
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Blake JA
N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
[No Abstract] [Full Text] [Related]
15. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
Pauriah M; Struthers AD; Lang CC
Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
[No Abstract] [Full Text] [Related]
16. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol lowering and ezetimibe.
Drazen JM; Jarcho JA; Morrissey S; Curfman GD
N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
[No Abstract] [Full Text] [Related]
18. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721
[TBL] [Abstract][Full Text] [Related]
19. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
Brown BG; Taylor AJ
N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
[No Abstract] [Full Text] [Related]
20. Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.
Toutouzas P; Richter D
Angiology; 2008; 59(2 Suppl):77S-9S. PubMed ID: 18628278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
